Randy Thurman
Fortune : 4 083 $ au 31/05/2026
Fortune : 4 083 $ au 31/05/2026
Ralph H.
Thurman was the founder of VIASYS Healthcare, Inc., founded in 2001, where the titles held included Chairman, President & Chief Executive Officer from 2001 to 2007.
Current jobs include Executive Chairman at ZEST Anchors LLC, Director at Pharmathen SA, Lead Independent Director at Outlook Therapeutics, Inc. starting in 2025, Director at Presbia USA, Inc., and Member at Levitt Equity Partners.
Former jobs include Chairman, President & Chief Executive Officer at SpiroTech; Chairman & Chief Executive Officer at Corning Life Sciences, Inc. from 1993 to 1997; President, Chief Executive Officer & Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1984 to 1993; Chairman & Chief Executive Officer at Strategic Reserves LLC from 1997 to 2001; Chairman at Enzon Pharmaceuticals, Inc. in 2001; Chairman at Orthofix Medical, Inc. from 2013 to 2014; Chairman at CardioNet LLC from 2010 to 2011; Vice Chairman at Arno Therapeutics, Inc. from 2014 to 2015; Executive Chairman at Presbia Holdings LLC from 2013 to 2015; Executive Chairman at Cogent HMG, Inc. from 2012 to 2014; Executive Chairman at Presbia PLC from 2014 to 2017; Director at Bausch Health Americas, Inc.; Director at Ikaria, Inc.; Independent Director at Veradigm, Inc. from 2012 to 2018; Independent Director at TFF Pharmaceuticals, Inc. from 2019 to 2022; Partner at AEA Investors LP in 2014; Senior Advisor at New Mountain Capital LLC; President at Rorer Group, Inc.; and Trustee at Pamplin College of Business.
Education includes undergraduate studies at Virginia Polytechnic Institute & State University, graduate studies at Webster University, and undergraduate studies at Air Command & Staff College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/05/2026 | 5 593 ( 0% ) | 4 083 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/01/2025 |
Levitt Equity Partners
Levitt Equity Partners Investment ManagersFinance Functions as private equity fund | Corporate Officer/Principal | - |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops drug delivery technologies for generic pharmaceutical products | Directeur/Membre du Conseil | - |
ZEST Anchors LLC
ZEST Anchors LLC Medical SpecialtiesHealth Technology Manufactures dental attachments | Président | - |
Presbia USA, Inc.
Presbia USA, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| TFF PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 30/09/2022 |
| VERADIGM INC. | Directeur/Membre du Conseil | 21/05/2018 |
| PRESBIA PLC | Président | 10/12/2017 |
| ARNO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/02/2015 |
| ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 28 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
AEA Investors LP
AEA Investors LP Investment ManagersFinance AEA Investors invests in middle-market companies located across the globe primarily in North America and Europe with an enterprise value of USD 400 million - 2.5 billion and an EBITDA of USD 5 - 200 million. The firm focuses on companies operating in the fields of industrial & industrial services, tech-enabled business services and tech-enabled healthcare services. It participates in buyout, growth, and debt transactions with an investment size of USD 50 – 250 million. The firm makes co-investments and acquires majority and minority interest. | Finance |
Orthofix Medical, Inc.
Orthofix Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets surgical products to the spine & orthopedic markets | Health Technology |
VIASYS Healthcare, Inc.
VIASYS Healthcare, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical and surgical devices and products | Health Technology |
CardioNet LLC
CardioNet LLC Medical SpecialtiesHealth Technology Provides cardiac monitoring services | Health Technology |
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
New Mountain Capital LLC
New Mountain Capital LLC Investment ManagersFinance New Mountain Capital invests in middle market companies located in the United States with an enterprise value of USD 100 - 1000 million. The firm focuses on a broad range of sectors and industries. It provides financing for add-on acquisitions, buyout and growth transactions with a transaction size ranging USD 100 - 500 million. It also acquires majority control and minority equity positions. | Finance |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Webster University
Webster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SpiroTech
SpiroTech Medical SpecialtiesHealth Technology Manufactures pulmonary-function-test analyzers | Health Technology |
Corning Life Sciences, Inc.
Corning Life Sciences, Inc. Home FurnishingsConsumer Durables Manufactures fiber-optics and specialty glasses | Consumer Durables |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Rorer Group, Inc.
Rorer Group, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Arno Therapeutics, Inc.
Arno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs | Health Technology |
Strategic Reserves LLC | |
ZEST Anchors LLC
ZEST Anchors LLC Medical SpecialtiesHealth Technology Manufactures dental attachments | Health Technology |
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops drug delivery technologies for generic pharmaceutical products | Health Technology |
Veradigm, Inc.
Veradigm, Inc. Packaged SoftwareTechnology Services Develops patient engagement software for healthcare organizations | Technology Services |
Presbia Holdings LLC
Presbia Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services | Commercial Services |
Cogent HMG, Inc.
Cogent HMG, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services and operates hospitals | Health Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Presbia PLC
Presbia PLC Medical SpecialtiesHealth Technology Develops, manufactures and commercializes Presbia Flexivue Microlens | Health Technology |
Presbia USA, Inc.
Presbia USA, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Air Command & Staff College
Air Command & Staff College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pamplin College of Business
Pamplin College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Levitt Equity Partners
Levitt Equity Partners Investment ManagersFinance Functions as private equity fund | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national